{"id":42038,"date":"2026-05-12T21:30:58","date_gmt":"2026-05-12T21:30:58","guid":{"rendered":"https:\/\/beyondtype1.org\/quienes-tienen-acceso-a-la-tecnologia-para-la-diabetes-y-quienes-no\/"},"modified":"2026-05-12T21:35:12","modified_gmt":"2026-05-12T21:35:12","slug":"acceso-tecnologia-diabetes","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/","title":{"rendered":"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">El acceso suele presentarse como algo positivo: cuanta m&aacute;s gente lo tenga, mejor. Pero cuando se trata de tecnolog&iacute;a para la diabetes, esa idea se ha vuelto m&aacute;s compleja. Dispositivos como <\/span><a href=\"https:\/\/beyondtype1.org\/es\/mcg-tendencia-o-conciencia\/\"><span style=\"font-weight: 400;\">Los sistemas de monitoreo continuo de glucosa (MCG) son cada vez m&aacute;s utilizados por personas sin diabetes<\/span><\/a><span style=\"font-weight: 400;\">, a<\/span><span style=\"font-weight: 400;\">&nbsp;menudo, por razones que no son vitales. Al mismo tiempo, a muchas personas con diabetes se les sigue negando el acceso a las herramientas que necesitan para sobrevivir. Entonces, &iquest;qui&eacute;n las recibe y qui&eacute;n no? La realidad del acceso a la tecnolog&iacute;a para la diabetes es m&aacute;s compleja de lo que parece. <\/span><\/p>\n<h3><strong>Hablando t&eacute;cnicamente<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">Es probable que ya sepas lo esencial que puede ser la tecnolog&iacute;a para la diabetes, pero en caso de que seas nuevo aqu&iacute;, aqu&iacute; tienes una breve introducci&oacute;n. Las herramientas m&aacute;s comunes incluyen monitores continuos de glucosa (MCG), bombas de insulina y sistemas automatizados de administraci&oacute;n de insulina (AID). Junto con estos, hay aplicaciones (e incluso <\/span><a href=\"https:\/\/beyondtype1.org\/es\/juego-level-one-facilita-manejo-diabetes-tipo-1\/\"><span style=\"font-weight: 400;\">juegos<\/span><\/a> <span style=\"font-weight: 400;\">) dise&ntilde;ados para apoyar el manejo diario.<\/span><\/p>\n<div class=\"sbi-embed-wrap\">\n<blockquote class=\"instagram-media sbi-embed\" data-instgrm-captioned data-instgrm-permalink=\"https:\/\/www.instagram.com\/reel\/DXw29duET_W\/?utm_source=ig_embed&amp;utm_campaign=loading\" data-instgrm-version=\"14\" style=\" background:#FFF; border:0; border-radius:3px; box-shadow:0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width:500px; min-width:326px; padding:0; width:99.375%; width:-webkit-calc(100% - 2px); width:calc(100% - 2px);\">\n<div style=\"padding:16px;\"> <a href=\"https:\/\/www.instagram.com\/reel\/DXw29duET_W\/?utm_source=ig_embed&amp;utm_campaign=loading\" style=\" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;\" target=\"_blank\" rel=\"noopener noreferrer\"> \n<div style=\" display: flex; flex-direction: row; align-items: center;\">\n<div style=\"background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;\"><\/div>\n<div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center;\">\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;\"><\/div>\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;\"><\/div>\n<\/div>\n<\/div>\n<div style=\"padding: 19% 0;\"><\/div>\n<div style=\"display:block; height:50px; margin:0 auto 12px; width:50px;\"><svg width=\"50px\" height=\"50px\" viewbox=\"0 0 60 60\" version=\"1.1\" xmlns=\"https:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"https:\/\/www.w3.org\/1999\/xlink\"><g stroke=\"none\" stroke-width=\"1\" fill=\"none\" fill-rule=\"evenodd\"><g transform=\"translate(-511.000000, -20.000000)\" fill=\"#000000\"><g><path d=\"M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631\"><\/path><\/g><\/g><\/g><\/svg><\/div>\n<div style=\"padding-top: 8px;\">\n<div style=\" color:#3897f0; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:550; line-height:18px;\">View this post on Instagram<\/div>\n<\/div>\n<div style=\"padding: 12.5% 0;\"><\/div>\n<div style=\"display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;\">\n<div>\n<div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);\"><\/div>\n<div style=\"background-color: #F4F4F4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;\"><\/div>\n<div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);\"><\/div>\n<\/div>\n<div style=\"margin-left: 8px;\">\n<div style=\" background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;\"><\/div>\n<div style=\" width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg)\"><\/div>\n<\/div>\n<div style=\"margin-left: auto;\">\n<div style=\" width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);\"><\/div>\n<div style=\" background-color: #F4F4F4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);\"><\/div>\n<div style=\" width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);\"><\/div>\n<\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center; margin-bottom: 24px;\">\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 224px;\"><\/div>\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 144px;\"><\/div>\n<\/div>\n<p><\/p><\/a><\/div>\n<\/blockquote>\n<p><script async src=\"\/\/platform.instagram.com\/en_US\/embeds.js\"><\/script><\/p><\/div>\n<p><span style=\"font-weight: 400;\">La tecnolog&iacute;a para la diabetes ha avanzado mucho y se ha convertido en un est&aacute;ndar de atenci&oacute;n m&eacute;dica, no en un lujo. Sin embargo, no todos tienen acceso a la informaci&oacute;n necesaria para tomar decisiones informadas sobre qu&eacute; herramientas son las m&aacute;s adecuadas para ellos. <\/span><\/p>\n<h3><strong>&iquest;Acceso denegado?<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">Las personas de bajos ingresos, aquellas con seguro p&uacute;blico o sin seguro m&eacute;dico, y las que viven en ciertas regiones geogr&aacute;ficas tienen muchas menos probabilidades de que se les receten o utilicen dispositivos como monitores continuos de glucosa (MCG) y bombas de insulina. Las disparidades persisten tambi&eacute;n seg&uacute;n la raza y el origen &eacute;tnico. En los entornos sanitarios, tanto los prejuicios conscientes como los inconscientes pueden influir en qui&eacute;n se considera un &laquo;buen candidato&raquo; para la tecnolog&iacute;a de la diabetes, a menudo mediante suposiciones sobre la adherencia al tratamiento, el coste o la capacidad de la persona para manejar los dispositivos. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">El sesgo consciente implica creencias de las que el profesional sanitario es consciente, mientras que el sesgo inconsciente act&uacute;a de forma m&aacute;s sutil, guiando decisiones sin darse cuenta, a menudo basadas en estereotipos o experiencias pasadas. En la atenci&oacute;n a la diabetes, esto puede afectar a qui&eacute;n se le ofrecen herramientas, formaci&oacute;n o tecnolog&iacute;a avanzada. Los profesionales sanitarios podr&iacute;an asumir que un paciente no ser&aacute; &laquo;adherente&raquo;, que no podr&aacute; permitirse los dispositivos o que no podr&aacute; manejar algo como un monitor continuo de glucosa o una bomba de insulina, especialmente en el caso de personas de comunidades marginadas. Incluso cuando no son intencionadas, estas suposiciones pueden limitar el acceso a una atenci&oacute;n que puede cambiar la vida y reforzar las desigualdades existentes. <\/span><\/p>\n<div class=\"sbi-embed-wrap\">\n<blockquote class=\"instagram-media sbi-embed\" data-instgrm-captioned data-instgrm-permalink=\"https:\/\/www.instagram.com\/p\/DVOzPilEj_x\/?utm_source=ig_embed&amp;utm_campaign=loading\" data-instgrm-version=\"14\" style=\" background:#FFF; border:0; border-radius:3px; box-shadow:0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width:500px; min-width:326px; padding:0; width:99.375%; width:-webkit-calc(100% - 2px); width:calc(100% - 2px);\">\n<div style=\"padding:16px;\"> <a href=\"https:\/\/www.instagram.com\/p\/DVOzPilEj_x\/?utm_source=ig_embed&amp;utm_campaign=loading\" style=\" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;\" target=\"_blank\" rel=\"noopener noreferrer\"> \n<div style=\" display: flex; flex-direction: row; align-items: center;\">\n<div style=\"background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;\"><\/div>\n<div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center;\">\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;\"><\/div>\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;\"><\/div>\n<\/div>\n<\/div>\n<div style=\"padding: 19% 0;\"><\/div>\n<div style=\"display:block; height:50px; margin:0 auto 12px; width:50px;\"><svg width=\"50px\" height=\"50px\" viewbox=\"0 0 60 60\" version=\"1.1\" xmlns=\"https:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"https:\/\/www.w3.org\/1999\/xlink\"><g stroke=\"none\" stroke-width=\"1\" fill=\"none\" fill-rule=\"evenodd\"><g transform=\"translate(-511.000000, -20.000000)\" fill=\"#000000\"><g><path d=\"M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631\"><\/path><\/g><\/g><\/g><\/svg><\/div>\n<div style=\"padding-top: 8px;\">\n<div style=\" color:#3897f0; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:550; line-height:18px;\">View this post on Instagram<\/div>\n<\/div>\n<div style=\"padding: 12.5% 0;\"><\/div>\n<div style=\"display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;\">\n<div>\n<div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);\"><\/div>\n<div style=\"background-color: #F4F4F4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;\"><\/div>\n<div style=\"background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);\"><\/div>\n<\/div>\n<div style=\"margin-left: 8px;\">\n<div style=\" background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;\"><\/div>\n<div style=\" width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg)\"><\/div>\n<\/div>\n<div style=\"margin-left: auto;\">\n<div style=\" width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);\"><\/div>\n<div style=\" background-color: #F4F4F4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);\"><\/div>\n<div style=\" width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);\"><\/div>\n<\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; flex-grow: 1; justify-content: center; margin-bottom: 24px;\">\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 224px;\"><\/div>\n<div style=\" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 144px;\"><\/div>\n<\/div>\n<p><\/p><\/a><\/div>\n<\/blockquote>\n<p><script async src=\"\/\/platform.instagram.com\/en_US\/embeds.js\"><\/script><\/p><\/div>\n<h3><strong>Barreras para una mejor atenci&oacute;n<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">Adem&aacute;s, barreras como las restricciones de los seguros y la escasa formaci&oacute;n de los proveedores influyen en las limitaciones de acceso. El resultado: muchas personas no obtienen las herramientas que m&aacute;s podr&iacute;an ayudarlas. Un ejemplo es Kalex Willzy, un creador de contenido del Reino Unido que vive con diabetes tipo 1. <\/span><a href=\"https:\/\/beyondtype1.org\/es\/kalex-willzy-diabetes-tipo-1\/\"> <span style=\"font-weight: 400;\">No sab&iacute;a que pod&iacute;a usar o incluso solicitar un monitor continuo de glucosa (MCG).<\/span><\/a><span style=\"font-weight: 400;\"> Hasta hace poco, a pesar de haber sido diagnosticado hace una d&eacute;cada. &laquo;Pensaba que si realmente necesitaba algo, los m&eacute;dicos me lo dir&iacute;an&raquo;, explic&oacute;. &laquo;Entonces alguien en internet me dijo: &laquo;&iquest;Por qu&eacute; no tienes uno? Tienes derecho a &eacute;l&raquo;. En mi siguiente cita lo ped&iacute;, y la enfermera literalmente sali&oacute; de la habitaci&oacute;n y regres&oacute; con uno. Sin m&aacute;s explicaciones&raquo;. <\/span><\/p>\n<h3><strong>La brecha es ruidosa<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">Una<\/span> <a href=\"https:\/\/diabetes.jmir.org\/2024\/1\/e54223\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">encuesta reciente<\/span><\/a><span style=\"font-weight: 400;\"> en un estudio sobre el uso de tecnolog&iacute;a digital, realizado con adultos con diabetes tipo 1 y tipo 2 en la cl&iacute;nica de diabetes del Hospital Grady Memorial en Atlanta, Georgia, pone de manifiesto una importante brecha en el acceso. Entre quienes nunca hab&iacute;an usado un monitor continuo de glucosa (MCG) (44%), la raz&oacute;n m&aacute;s com&uacute;n no fue el costo ni la preferencia, sino simplemente que nunca se les hab&iacute;a ofrecido uno (64%). Otros encuestados se&ntilde;alaron el costo como una barrera (12%). <\/span><\/p>\n<p><span style=\"font-weight: 400;\">La ADA (Asociaci&oacute;n Americana de Diabetes) tambi&eacute;n<\/span> <a href=\"https:\/\/diabetes.org\/about-diabetes\/health-equity-commitment\/technology-access\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">subraya lo sist&eacute;micas que<\/span><\/a> <span style=\"font-weight: 400;\">son estas deficiencias:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Si recibes<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/emergencia-salud-publica-medicaid\/\"><span style=\"font-weight: 400;\">Medicaid<\/span><\/a><span style=\"font-weight: 400;\">, es mucho menos probable que obtengas un monitor continuo de glucosa (MCG), especialmente si eres una persona de color.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">El acceso al monitoreo continuo de glucosa es menor en el sureste, donde los &iacute;ndices de pobreza son m&aacute;s altos y la mortalidad por diabetes supera el 20%. <\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los adultos mayores con diabetes tienen menos probabilidades de que se les receten monitores continuos de glucosa (MCG) que a las personas m&aacute;s j&oacute;venes.<\/span><\/li>\n<\/ul>\n<h3><strong>&iquest;Qu&eacute; necesita cambiar?<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">Cuando la tecnolog&iacute;a para la diabetes no est&aacute; disponible para todos por igual, el impacto se hace evidente r&aacute;pidamente; no solo en los datos, sino tambi&eacute;n en la vida real. La falta de acceso puede significar m&aacute;s complicaciones, m&aacute;s visitas a urgencias y mayores costos a largo plazo. Tambi&eacute;n puede a&ntilde;adir una carga mental, lo que lleva a <\/span><a href=\"https:\/\/beyondtype1.org\/es\/entender-el-burnout-de-la-diabetes\/\"><span style=\"font-weight: 400;\">agotamiento<\/span><\/a> <span style=\"font-weight: 400;\">y sensaci&oacute;n de haber sido abandonado.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">&iquest;La buena noticia? El impulso est&aacute; creciendo y la presi&oacute;n por una atenci&oacute;n m&aacute;s equitativa se est&aacute; haciendo cada vez m&aacute;s fuerte. Pero, &iquest;qu&eacute; puedes hacer ahora mismo? Empieza por defender tus propios derechos. <a href=\"https:\/\/beyondtype1.org\/es\/abogar-por-tecnologia-para-la-diabetes\/\">Aprende qu&eacute; decir cuando un proveedor te dice &laquo;no&raquo;<\/a> y <\/span><a href=\"https:\/\/beyondtype1.org\/es\/como-defenderse-en-la-farmacia-una-guia-para-acceder-a-la-insulina\/\"> <span style=\"font-weight: 400;\">c&oacute;mo expresarse en la farmacia<\/span><\/a><span style=\"font-weight: 400;\"> Si encuentras obst&aacute;culos para conseguir insulina o insumos, peque&ntilde;os gestos de defensa pueden generar un cambio real. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">&iquest;Quieres profundizar en la equidad en salud en la atenci&oacute;n de la diabetes? Explora <\/span> <a href=\"https:\/\/beyondtype1.org\/diabetes-grant-funding-with-beyond-barriers\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">el programa Beyond Barriers<\/span><\/a> y el <a href=\"https:\/\/beyondtype1.org\/underserved-diabetes-organizations\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">directorio de recursos<\/span><\/a> <span style=\"font-weight: 400;\">para encontrar organizaciones que apoyan a las comunidades desfavorecidas.<\/span><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>El acceso suele presentarse como algo positivo: cuanta m&aacute;s gente lo tenga, mejor. Pero cuando se trata de tecnolog&iacute;a para la diabetes, esa idea se ha vuelto m&aacute;s compleja. Dispositivos como Los sistemas de monitoreo continuo de glucosa (MCG) son cada vez m&aacute;s utilizados por personas sin diabetes, a&nbsp;menudo, por razones que no son vitales. [&hellip;]<\/p>\n","protected":false},"author":26,"featured_media":42034,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-42038","resources","type-resources","status-publish","has-post-thumbnail","hentry","content-categories-educacion","topics-cuidado-de-la-salud","topics-tecnologia-y-equipamiento","diabetes-types-tipo-1","tags-bomba-de-insulina","tags-defensa","tags-mcg","tags-mcg-es-2","tags-tecnologia-para-el-manejo-de-la-diabetes","tags-tecnologia-para-la-diabetes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no? | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"La tecnolog\u00eda para la diabetes salva vidas, pero no todos tienen acceso a ella. Analizamos la brecha de acceso, los prejuicios de los profesionales sanitarios y los cambios necesarios.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no? | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"La tecnolog\u00eda para la diabetes salva vidas, pero no todos tienen acceso a ella. Analizamos la brecha de acceso, los prejuicios de los profesionales sanitarios y los cambios necesarios.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-12T21:35:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/05\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1380\" \/>\n\t<meta property=\"og:image:height\" content=\"776\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/\",\"name\":\"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no? | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg\",\"datePublished\":\"2026-05-12T21:30:58+00:00\",\"dateModified\":\"2026-05-12T21:35:12+00:00\",\"description\":\"La tecnolog\u00eda para la diabetes salva vidas, pero no todos tienen acceso a ella. Analizamos la brecha de acceso, los prejuicios de los profesionales sanitarios y los cambios necesarios.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg\",\"contentUrl\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg\",\"width\":1380,\"height\":776},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/acceso-tecnologia-diabetes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/header-logo.svg\",\"contentUrl\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/beyondtype1\",\"https:\\\/\\\/x.com\\\/BeyondType1\",\"http:\\\/\\\/instagram.com\\\/BeyondType1\\\/\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/BeyondType1\",\"https:\\\/\\\/www.tiktok.com\\\/@beyondtype1\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/beyond-type1\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no? | Beyond Type 1","description":"La tecnolog\u00eda para la diabetes salva vidas, pero no todos tienen acceso a ella. Analizamos la brecha de acceso, los prejuicios de los profesionales sanitarios y los cambios necesarios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/","og_locale":"es_ES","og_type":"article","og_title":"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no? | Beyond Type 1","og_description":"La tecnolog\u00eda para la diabetes salva vidas, pero no todos tienen acceso a ella. Analizamos la brecha de acceso, los prejuicios de los profesionales sanitarios y los cambios necesarios.","og_url":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2026-05-12T21:35:12+00:00","og_image":[{"width":1380,"height":776,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/05\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/","url":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/","name":"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no? | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/05\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg","datePublished":"2026-05-12T21:30:58+00:00","dateModified":"2026-05-12T21:35:12+00:00","description":"La tecnolog\u00eda para la diabetes salva vidas, pero no todos tienen acceso a ella. Analizamos la brecha de acceso, los prejuicios de los profesionales sanitarios y los cambios necesarios.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/05\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/05\/BT1_Article-Header_Who-Gets-Diabetes-Tech-and-Who-Doesnt_Option-1_2271778269.jpg","width":1380,"height":776},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/acceso-tecnologia-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"\u00bfQui\u00e9nes tienen acceso a la tecnolog\u00eda para la diabetes y qui\u00e9nes no?"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/42038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=42038"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/42038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/42034"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=42038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}